The New Omega

Asset 1.png
CardiOmegia Logo.png

What is CardiOmegia™?

CardiOmegia™ is extracted from the fruit of an ancient plant grown in Tibetan Plateau called sea buckthorn. With our advanced supercritical CO₂ extraction and purification technology, we are capable of extracting 45% Omega 7 in the natural triglyceride (TG) form.


What is Omega 7?

Omega 7 is a novel unsaturated fatty acid that was first discovered by scientists at Harvard Medical School in 2008.

Researches have shown that Omega 7 is effective in preventing cardiovascular disease and plays a key role in metabolic syndrome, which helps in:

  • Maintaining normal blood pressure

  • Reducing insulin resistance

  • Fighting chronic inflammation

  • Suppressing appetite to aid weight management

  • Lowering LDL

  • Increasing HDL

  • Reducing blood sugar and serum triglyceride


 Mechanism of Action

CardiOmegia Mechanism of Action.png

Omega 7 Effects on C-Reactive Protein and Serum Lipids


Design: 30-day parallel, double-blinded, randomized, placebo-controlled study with 60 healthy participants. 

Dosage: 220.5 mg of Omega 7 per day for 1 month.


Significant reduction in:

  • C-Reactive Protein (CRP) by 44%,

  • Triglyceride (TG) by 15%,

  • Low-Density Lipoprotein (LDL) by 8%

Significant increase in High-Density Lipoprotein (HDL) by 5%

(Bernstein, Roizen and Martinez, 2014)


Omega 7 Comparison


With our advanced supercritical CO₂ extraction and purification technology, CardiOmegia™ offers up to 45% Omega 7 in its natural triglyceride form, which is up to 4.5X higher when compared with other Omega 7 source.


With just 1 x 500mg CardiOmegia softgel per day,

it can meet with the dosage used in a clinical trial.

CardiOmegia Softgel.jpg



CardiOmegia™ Oil


CardiOmegia™ Powder

CariOmegia Powder.png

Certified with the followings:


Recommended Daily Intake: 0.5g per day

Shelf-Life: 3 years

Recommended Daily Intake: 1.5g per day

Shelf-Life: 3 years


Technical Document

Product Brochure

Specification - CardiOmegia

CardiOmegia Specification Cover.png

Specification - CardiOmegia Powder


Regulatory Info. - CardiOmegia


Regulatory Info. - CardiOmegia Powder

CardiOmegia Powder Regulatory Information.png


  1. Bernstein, A., Roizen, M. and Martinez, L. (2014). Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled study. Journal of Clinical Lipidology, [online] 8(6), pp.612-617. Available at: